Chapter 154. Pediatric Neurotransmitter Diseases

  1. Robert P. Lisak MD, FAAN, FRCP Parker Webber Chair Professor Chair Neurologist-in-Chief Chief2,3,
  2. Daniel D. Truong MD, FAAN Head4,
  3. William M. Carroll MBBS, MD, FRACP, FRCP(E) Head5 and
  4. Roongroj Bhidayasiri MD, FRCP Director6,7
  1. Stephen Deputy MD, FAAP Associate Professor

Published Online: 18 MAY 2010

DOI: 10.1002/9781444317008.ch154

International Neurology: A Clinical Approach

International Neurology: A Clinical Approach

How to Cite

Deputy, S. (2010) Pediatric Neurotransmitter Diseases, in International Neurology: A Clinical Approach (eds R. P. Lisak, D. D. Truong, W. M. Carroll and R. Bhidayasiri), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444317008.ch154

Editor Information

  1. 2

    Wayne State University School of Medicine, Detroit, MI, USA

  2. 3

    Detroit Medical Center, Harper University Hospital, Detroit, MI, USA

  3. 4

    The Parkinson and Movement Disorder Institute, Memorial Neuroscience Institute, Orange Coast Memorial Medical Center, Fountain Valley, CA, USA

  4. 5

    Sir Charles Gairdner Hospital, Nedlands, Perth, Australia

  5. 6

    Chulalongkorn Comprehensive Movement Disorders Center, Chulalongkorn University Hospital, Bangkok, Thailand

  6. 7

    University of California at Los Angeles, School of Medicine, Los Angeles, CA, USA

Author Information

  1. Louisiana State University School of Medicine, New Orleans, LA, USA

Publication History

  1. Published Online: 18 MAY 2010
  2. Published Print: 11 SEP 2009

ISBN Information

Print ISBN: 9781405157384

Online ISBN: 9781444317008

SEARCH

Keywords:

  • pediatric neurotransmitter diseases;
  • pediatric neurotransmitter disorders, challenging group of rare neurometabolic disorders;
  • monoamine neurotransmitter disorders;
  • GTP cyclohydrolase I deficiency - GCH-I deficiency, Segawa disease;
  • monoamine metabolism;
  • tyrosine hydroxylase (TH) deficiency;
  • TH catalyzing hydroxylation of tyrosine to L-dopa;
  • sepiapterin reductase (SR) deficiency;
  • GABA neurotransmitter disorders;
  • aromatic L-amino acid decarboxylase (AADC) deficiency

Summary

This chapter contains sections titled:

  • Introduction

  • Pathophysiology

  • Monoamine neurotransmitter disorders

  • GABA neurotransmitter disorders

  • Further reading